-transparent.png){kind=logo}
In this experiment, we synthetized new 2-methyl-3-aminopropiophenone (MP) derivatives, whose structure is known to have central muscle relaxant activities, and quinolizidine and indan . tetralin derivatives derived from MP by cyclization, and we investigated the central muscle relaxant activity. Among the quinolizidine derivatives, there was a very strong central depressant agent, trans (3H, 9aH)-3-(p-chloro) benzoyl-quinolizidine (HSR-740), and among the indan . tetralin derivatives, there was an excitant agents, trans (1H, 2H)-5-methoxy-3, 3-dimethyl-2-piperidinomethyl indan-1-ol (HSR-719). From the results, these derivatives were not considered to be adequate for central muscle relaxant. Among the MP derivatives, (4'-chloro-2'-methoxy-3-piperidino) propiophenone HCl (HSR-733) and (4'-ethyl-2-methyl-3-pyrrolidino) propiophenone HCl (HSR-770) strongly inhibited the cooperative movement in the rotating rod method using mice, and it exerted almost the same depressant activity on the cross extensor reflex using alpha-chloralose anesthetized rats. However, the inhibitory effects of HSR-733 on the anemic decerebrate rigidity and the rigidity induced by intracollicular decerebration in rats were weaker than those of HSR-770 and eperisone. In spinal cats, at a low dose (5 mg/kg, i.v.), HSR-733 depressed monosynaptic and dorsal root reflex potentials as compared with polysynaptic reflex potentials, and inhibitory effects of HSR-733 on these three reflex potentials were more potent than those of eperisone and HSR-770. Although HSR-770 acts on the spinal cord and supraspinal level on which eperisone has been reported to act, HSR-733 may mainly act on the spinal cord. These results indicate that the MP derivative with a 2-methyl group may be suitable as a central muscle relaxant. HSR-770, which has equipotent muscle relaxant activity to eperisone, exerted strong inhibitory effects on oxotremorine-induced tremor and weak inhibitory effects on spontaneous motor activity in the Animex method using mice, as compared with eperisone.
H Kontani, and
A Mano, and
R Koshiura, and
M Yamazaki, and
Y Shimada, and
M Oshita, and
K Morikawa, and
H Kato, and
Y Ito
September 1987,
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
H Kontani, and
A Mano, and
R Koshiura, and
M Yamazaki, and
Y Shimada, and
M Oshita, and
K Morikawa, and
H Kato, and
Y Ito
January 1979,
Acta pharmaceutica Suecica,
H Kontani, and
A Mano, and
R Koshiura, and
M Yamazaki, and
Y Shimada, and
M Oshita, and
K Morikawa, and
H Kato, and
Y Ito
December 1997,
Farmaco (Societa chimica italiana : 1989),
H Kontani, and
A Mano, and
R Koshiura, and
M Yamazaki, and
Y Shimada, and
M Oshita, and
K Morikawa, and
H Kato, and
Y Ito
March 1987,
Arzneimittel-Forschung,
H Kontani, and
A Mano, and
R Koshiura, and
M Yamazaki, and
Y Shimada, and
M Oshita, and
K Morikawa, and
H Kato, and
Y Ito
February 1985,
Il Farmaco; edizione scientifica,
H Kontani, and
A Mano, and
R Koshiura, and
M Yamazaki, and
Y Shimada, and
M Oshita, and
K Morikawa, and
H Kato, and
Y Ito
September 1974,
Journal of medicinal chemistry,
H Kontani, and
A Mano, and
R Koshiura, and
M Yamazaki, and
Y Shimada, and
M Oshita, and
K Morikawa, and
H Kato, and
Y Ito
November 1981,
Indian journal of experimental biology,
H Kontani, and
A Mano, and
R Koshiura, and
M Yamazaki, and
Y Shimada, and
M Oshita, and
K Morikawa, and
H Kato, and
Y Ito
September 1970,
Neuropharmacology,
H Kontani, and
A Mano, and
R Koshiura, and
M Yamazaki, and
Y Shimada, and
M Oshita, and
K Morikawa, and
H Kato, and
Y Ito
April 1961,
Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti,
H Kontani, and
A Mano, and
R Koshiura, and
M Yamazaki, and
Y Shimada, and
M Oshita, and
K Morikawa, and
H Kato, and
Y Ito
January 1966,
Acta poloniae pharmaceutica,
